Section Arrow
Quote
KRSA.NASDAQ
- Korsana Biosciences Inc
Quotes are at least 15-min delayed:2026/09/09 16:12 EDT
After Hours
Last
 27.5997
+1.3997 (+5.34%)
Bid
21
Ask
29.1
High 28.93 
Low 25.3 
Volume 612 
Regular Hours (Closed)
Last
 26.2
+2.68 (+11.39%)
Day High 
26.2 
Prev. Close
23.52 
1-M High
-- 
Volume 
27.13K 
Bid
21
Ask
29.1
Day Low
21.0001 
Open
24.42 
1-M Low
-- 
Market Cap 
2.25M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA -- 
20-SMA -- 
50-SMA -- 
52-W High -- 
52-W Low -- 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-11.62/-0.99
Enterprise Value
2.25M
Balance Sheet
Book Value Per Share
7.61
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
2.07M
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
IRDOpus Genetics Inc5.74+1.4+32.26%-- 
After Hours 5.7629 -- --
OCGNOcugen1.0662-0.2638-19.83%-- 
After Hours 1.085 -- --
GOSSGossamer Bio0.15985-0.02005-11.15%-- 
After Hours 0.160499 -- --
PDSBPDS Biotechnology Corp0.2935-0.0065-2.17%-- 
After Hours 0.292 -- --
ATAIAtaiBeckley Inc7.31+0.03+0.41%-- 
After Hours 7.31 -- --
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. The company focuses on enabling the full therapeutic potential of next-generation sGC stimulators and neuropsychiatric diseases. Its pipeline products include Olinciguat, Praliciguat, and others.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.